Showing results (301-310 of 408) with videos related to
Sort By:
Pageof 41
International Journal of Cancer|June 30, 2020
Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinomaXin Zhang, Tim Zegar, Tim Weiser, et al.Cancer Letters|September 18, 2013
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer modelsBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.HLA|April 15, 2025
The Identification of 56 Novel HLA Alleles in Hong Kong Chinese Individuals in 2024Alan L M Li, Stephen K F Cheung, Albert J E French, et al.Stroke|May 22, 2023
Location-Specific Hematoma Volume Cutoff and Clinical Outcomes in Intracerebral HemorrhageKay-Cheong Teo, Sze-Man Fong, William C Y Leung, et al.Cancer Research|April 23, 2011
EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesisAlfred S L Cheng, Suki S Lau, Yangchao Chen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCCJ J Knox, C H Barrios, T M Kim, et al.JAMA Oncology|December 29, 2022
Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-Free DNA in Patients With Non-Small Cell Lung CancerKirsty W C Lee, Molly S C Li, Wanxia Gai, et al.World Neurosurgery|June 15, 2016
Subthalamic Nucleus Deep Brain Stimulation for Parkinson Disease in Hong Kong: A Prospective Territory-Wide 2-Year Follow-Up StudyDanny T M Chan, Cannon X L Zhu, Claire K Y Lau, et al.Nature Communications|January 4, 2019
Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entryYen-Ting Lai, Tao Wang, Sijy O'Dell, et al.Nature Biotechnology|July 29, 2020
Inducible de novo expression of neoantigens in tumor cells and miceMartina Damo, Brittany Fitzgerald, Yisi Lu, et al.Pageof 41